Analysts’ Opinions Are Mixed on These Financial Stocks: Manulife Financial (MFC) and Swiss Re AG (OtherSSREF)
Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Manulife Financial (MFC – Research Report) and Swiss Re AG (SSREF – Research Report).
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Manulife Financial (MFC)
CIBC analyst Paul Holden maintained a Hold rating on Manulife Financial today. The company’s shares closed last Tuesday at $33.46.
According to TipRanks.com, Holden is a 5-star analyst with an average return of
Manulife Financial has an analyst consensus of Moderate Buy, with a price target consensus of $40.76, a 21.3% upside from current levels. In a report issued on November 14, Barclays also maintained a Hold rating on the stock with a C$49.00 price target.
See the top stocks recommended by analysts >>
Swiss Re AG (SSREF)
In a report released today, Claudia Gaspari from Barclays maintained a Sell rating on Swiss Re AG, with a price target of CHF133.00. The company’s shares closed last Monday at $180.39.
Gaspari has an average return of
According to TipRanks.com, Gaspari is ranked #1107 out of 10123 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for Swiss Re AG with a $178.98 average price target, implying a -0.6% downside from current levels. In a report issued on November 14, RBC Capital also maintained a Sell rating on the stock with a CHF125.00 price target.
Read More on MFC:
Disclaimer & DisclosureReport an Issue
- Manulife Financial price target raised to $50 from $47 at Morgan Stanley
- Manulife Financial price target raised to C$50 from C$49 at CIBC
- Manulife Financial price target raised to C$52 from C$49 at RBC Capital
- Manulife Financial price target raised to C$58 from C$53 at BMO Capital
- Manulife Financial price target raised to C$49 from C$48 at Barclays
